KURE Stock Overview
KraneShares Trust - KraneShares MSCI All China Health Care Index ETF is an exchange traded fund launched and managed by Krane Funds Advisors, LLC.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
KraneShares Trust - KraneShares MSCI All China Health Care Index ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$14.17 |
52 Week High | US$21.08 |
52 Week Low | US$13.60 |
Beta | 0 |
1 Month Change | -3.61% |
3 Month Change | -11.47% |
1 Year Change | -29.65% |
3 Year Change | -66.45% |
5 Year Change | -35.86% |
Change since IPO | -42.68% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
KURE | US Capital Markets | US Market | |
---|---|---|---|
7D | 2.3% | -0.7% | -3.2% |
1Y | -29.6% | 23.2% | 19.3% |
Return vs Industry: KURE underperformed the US Capital Markets industry which returned 23.2% over the past year.
Return vs Market: KURE underperformed the US Market which returned 19.3% over the past year.
Price Volatility
KURE volatility | |
---|---|
KURE Average Weekly Movement | 4.0% |
Capital Markets Industry Average Movement | 3.4% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.5% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: KURE has not had significant price volatility in the past 3 months.
Volatility Over Time: KURE's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2018 | n/a | n/a | kraneshares.com/kure/ |
KraneShares Trust - KraneShares MSCI All China Health Care Index ETF is an exchange traded fund launched and managed by Krane Funds Advisors, LLC. The fund invests in public equity markets of China. The fund invests in stocks of companies operating across health care sectors.
KraneShares Trust - KraneShares MSCI All China Health Care Index ETF Fundamentals Summary
KURE fundamental statistics | |
---|---|
Market cap | US$44.91m |
Earnings (TTM) | US$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs KURE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
KURE income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$0 |
Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did KURE perform over the long term?
See historical performance and comparison